Home › Pharmaco-Kinesis Corporation Develops First Combinatorial Nano-Drug TNT
 

Keywords :   


Pharmaco-Kinesis Corporation Develops First Combinatorial Nano-Drug TNT

2013-04-30 09:00:00| drugdiscoveryonline News Articles

Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart implantable pumps and medications for local drug delivery, recently reported development of the first combinatorial nano-drug product candidate, a combination of Temozolomide (Merck & Co.) and Thalidomide (Celgene) nanoparticles to be tested for treatment of gliomas and other cancers

Tags: corporation develops tnt combinatorial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Genesus to restructure with Canada ZF Investments
03.07Global trade, domestic policy: What's at stake for pork industry
03.07Over 20,000 Tesco staff to split 30m from share schemes
03.07Ex-Post Office chair denies hiding key Horizon report
03.07Print Quest invests in two more Miraclon Shine LED lamp kits
03.07ETI celebrates grand opening of new headquarters in Spain
03.07Mondi unveils FlexiBag Reinforced
03.07Nilpeter announces new partnership in the Philippines
More »